Dr. Leonard G. Gomella Studies the Effect of Dutasteride on the Risk of Prostate Cancer

2
Apr

GomellaLeonardG

Dr. Leonard G. Gomella

Dr. Leonard G. Gomella and colleagues conducted a landmark international
randomized, double-blind, placebo-controlled, parallel-group multi-center
clinical trial to determine whether dutasteride reduces the risk of incident
prostate cancer, as detected on biopsy, among men who are at increased risk for
the disease. Over the course of the 4-year study period, dutasteride reduced
the risk of incident prostate cancer detected on biopsy and improved the
outcomes related to benign prostatic hyperplasia. These results were published
in the New England Journal of Medicine on April 1, 2010 ( Pubmed Abstract ).